Relapsing-remitting multiple sclerosis (RRMS) is the most common type of multiple sclerosis (MS), making up about 85% of diagnoses. RRMS involves periods known as relapses, during which symptoms ...

1 A study focused specifically on people with RRMS To better understand PWB among patients with relapsing-remitting multiple sclerosis (RRMS), a pair of researchers—from Pennsylvania State ...

Avonex® IFN-β-1a im. weekly RRMS and 'early therapy' in patients with an initial demyelinating event and high risk of occurrence of clinically definite MS Rebif® IFN-β-1a sc. three times a ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

The evaluated cohort of RRMS patients included 630 cases ... Corticosteroids (usually used for the treatment of MS relapses) prescribed most often included intravenous methylprednisolone (used ...

They have a 20% chance of receiving an MS diagnosis in the same amount of time. RRMS is characterized by clearly defined relapses of increased disease activity and worsening symptoms. These are ...

A small trial enrolled 62 people with RRMS who showed signs of cognitive dysfunction to test the effectiveness of acupuncture ...

The National MS Society has employment resources that can help. Many people who receive an initial diagnosis of ...

“It all looks normal,” Rebeckah Price’s first optometrist told her on January 3, 2023. Inside of the small, sterile room, the ...

The following is a summary of “Cost–consequence analysis of early vs. delayed natalizumab use in highly active ...